Cited by 241Attention Deficit Hyperactivity DisorderNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.

Open access
Vivienne Ann Russell, Robert D. Oades, Rosemary Tannock, Peter R. Killeen, Judith G Auerbach, Espen Borgå Johansen, Terje Sagvolden·2006·Behavioral and Brain Functions

Abstract

BACKGROUND: Current concepts of Attention-Deficit/Hyperactivity Disorder (ADHD) emphasize the role of higher-order cognitive functions and reinforcement processes attributed to structural and biochemical anomalies in cortical and limbic neural networks innervated by the monoamines, dopamine, noradrenaline and serotonin. However, these explanations do not account for the ubiquitous findings in ADHD of intra-individual performance variability, particularly on tasks that require continual responses to rapid, externally-paced stimuli. Nor do they consider attention as a temporal process dependent upon a continuous energy supply for efficient and consistent function. A consideration of this feature of intra-individual response variability, which is not unique to ADHD but is also found in other disorders, leads to a new perspective on the causes and potential remedies of specific aspects of ADHD. THE HYPOTHESIS: We propose that in ADHD, astrocyte function is insufficient, particularly in terms of its formation and supply of lactate. This insufficiency has implications both for performance and development: H1) In rapidly firing neurons there is deficient ATP production, slow restoration of ionic gradients across neuronal membranes and delayed neuronal firing; H2) In oligodendrocytes insufficient lactate supply impairs fatty acid synthesis and myelination of axons during development. These effects occur over vastly different time scales: those due to deficient ATP (H1) occur over milliseconds, whereas those due to deficient myelination (H2) occur over months and years. Collectively the neural outcomes of impaired astrocytic release of lactate manifest behaviourally as inefficient and inconsistent performance (variable response times across the lifespan, especially during activities that require sustained speeded responses and complex information processing). TESTING THE HYPOTHESIS: Multi-level and multi-method approaches are required. These include: 1) Use of dynamic strategies to evaluate cognitive performance under conditions that vary in duration, complexity, speed, and reinforcement; 2) Use of sensitive neuroimaging techniques such as diffusion tensor imaging, magnetic resonance spectroscopy, electroencephalography or magnetoencephalopathy to quantify developmental changes in myelination in ADHD as a potential basis for the delayed maturation of brain function and coordination, and 3) Investigation of the prevalence of genetic markers for factors that regulate energy metabolism (lactate, glutamate, glucose transporters, glycogen synthase, glycogen phosphorylase, glycolytic enzymes), release of glutamate from synaptic terminals and glutamate-stimulated lactate production (SNAP25, glutamate receptors, adenosine receptors, neurexins, intracellular Ca2+), as well as astrocyte function (alpha1, alpha2 and beta-adrenoceptors, dopamine D1 receptors) and myelin synthesis (lactate transporter, Lingo-1, Quaking homolog, leukemia inhibitory factor, and Transferrin). IMPLICATIONS OF THE HYPOTHESIS: The hypothesis extends existing theories of ADHD by proposing a physiological basis for specific aspects of the ADHD phenotype - namely frequent, transient and impairing fluctuations in functioning, particularly during performance of speeded, effortful tasks. The immediate effects of deficient ATP production and slow restoration of ionic gradients across membranes of rapidly firing neurons have implications for daily functioning: For individuals with ADHD, performance efficacy would be enhanced if repetitive and lengthy effortful tasks were segmented to reduce concurrent demands for speed and accuracy of response (introduction of breaks into lengthy/effortful activities such as examinations, motorway driving, assembly-line production). Also, variations in task or modality and the use of self- rather than system-paced schedules would be helpful. This would enable energetic demands to be distributed to alternate neural resources, and energy reserves to be re-established. Longer-term effects may manifest as reduction in regional brain volumes since brain areas with the highest energy demand will be most affected by a restricted energy supply and may be reduced in size. Novel forms of therapeutic agent and delivery system could be based on factors that regulate energy production and myelin synthesis. Since the phenomena and our proposed basis for it are not unique to ADHD but also manifests in other disorders, the implications of our hypotheses may be relevant to understanding and remediating these other conditions as well.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1744-9081-2-30

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 86

  1. Biederman J, Faraone SV: Attention-deficit hyperactivity disor- der. Lancet 2005, 366:237-248.
  2. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, Johnston JA, Spencer T, Ustun TB: The prevalence and effects of adult attention deficit/hyperactivity disorder on work per- formance in a nationally representative sample of workers. J Occup Environ Med 2005, 47:565-572.
  3. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M: Functional impairments in adults with self-reports of diag- nosed ADHD: A controlled study of 1001 adults in the com- munity. J Clin Psychiatry 2006, 67:524-540.
  4. Houghton S, Douglas G, West J, Whiting K, Wall M, Langsford S, Powell L, Carroll A: Differential patterns of executive function in children with ADHD according to gender and subtype. J Child Neurol 1999, 14:801-805.
  5. Douglas VI: Cognitive control processes in Attention-Deficit/ Hyperractivity Disorder. In Handbook of Disruptive Behavior Disor- ders Edited by: Quay HC and Hogan AE. New York, Plenum; 1999:105-138.
  6. Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney WE: A naturalistic assessment of the motor activity of hyperac- tive boys. I. Comparison with normal controls. Arch Gen Psy- chiatry 1983, 40:681-687.
  7. Aase H, Sagvolden T: Moment-to-moment dynamics of ADHD behaviour. Behav Brain Funct 2005, 1:12.
  8. Aase H, Meyer A, Sagvolden T: Moment-to-moment dynamics of ADHD behaviour in South African children. Behav Brain Funct 2006, 2:11.
  9. Jessen KR: Glial cells. Int J Biochem Cell Biol 2004, 36:1861-1867.
  10. Ostrow LW, Sachs F: Mechanosensation and endothelin in astrocytes--hypothetical roles in CNS pathophysiology. Brain Res Brain Res Rev 2005, 48:488-508.
  11. Todd RD, Botteron KN: Is attention-deficit/hyperactivity disor- der an energy deficiency syndrome? Biol Psychiatry 2001, 50:151-158.
  12. Sanchez-Abarca LI, Tabernero A, Medina JM: Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 2001, 36:321-329.
  13. Miyazaki I, Asanuma M, az-Corrales FJ, Miyoshi K, Ogawa N: Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res 2004, 1029:120-123.
  14. Moldrich RX, Aprico K, Diwakarla S, O'Shea RD, Beart PM: Astro- cyte mGlu(2/3)-mediated cAMP potentiation is calcium sen- sitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology 2002, 43:189-203.
  15. Grimaldi M, Florio T, Schettini G: Somatostatin inhibits inter- leukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase. Biochem Biophys Res Commun 1997, 235:242-248.
  16. Hirst WD, Cheung NY, Rattray M, Price GW, Wilkin GP: Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase. Brain Res Mol Brain Res 1998, 61:90-99.
  17. Sagvolden T, Johansen EB, Aase H, Russell VA: A dynamic develop- mental theory of Attention-Deficit/Hyperactivity Disorder (ADHD) predominantly hyperactive/impulsive and com- bined subtypes. Behav Brain Sci 2005, 28:397-419.
  18. Fozard JL, Vercryssen M, Reynolds SL, Hancock PA, Quilter RE: Age differences and changes in reaction time: the Baltimore Lon- gitudinal Study of Aging. J Gerontol 1994, 49:179-189.
  19. Hultsch DF, MacDonald SW, Dixon RA: Variability in reaction time performance of younger and older adults. J Gerontol B Psy- chol Sci Soc Sci 2002, 57:101-115.
  20. Burton CL, Strauss E, Hultsch DF, Moll A, Hunter MA: Intraindivid- ual variability as a marker of neurological dysfunction: a comparison of Alzheimer's disease and Parkinson's disease. J Clin Exp Neuropsychol 2006, 28:67-83.
  21. Stuss DT, Stethem LL, Picton TW, Leech EE, Pelchat G: Traumatic brain injury, aging and reaction time. Can J Neurol Sci 1989, 16:161-167.
  22. Stuss DT, Murphy KJ, Binns MA, Alexander MP: Staying on the job: the frontal lobes control individual performance variability. Brain 2003, 126:2363-2380.
  23. Bunce D, MacDonald SW, Hultsch DF: Inconsistency in serial choice decision and motor reaction times dissociate in younger and older adults. Brain Cogn 2004, 56:320-327.
  24. West R, Murphy KJ, Armilio ML, Craik FI, Stuss DT: Lapses of intention and performance variability reveal age-related increases in fluctuations of executive control. Brain Cogn 2002, 49:402-419.
  25. Strauss E, Slick DJ, Levy-Bencheton J, Hunter M, MacDonald SW, Hultsch DF: Intraindividual variability as an indicator of malin- gering in head injury. Arch Clin Neuropsychol 2002, 17:423-444.
  26. Bellgrove MA, Hester R, Garavan H: The functional neuroana- tomical correlates of response variability: evidence from a response inhibition task. Neuropsychologia 2004, 42:1910-1916.
  27. Salthouse TA: Attentional blocks are not responsible for age- related slowing. J Gerontol 1993, 48:263-270.
  28. Gottlob LR: Location cuing and response time distributions in visual attention. Percept Psychophys 2004, 66:1293-1302.
  29. Williams BR, Hultsch DF, Strauss EH, Hunter MA, Tannock R: Incon- sistency in reaction time across the life span. Neuropsychology 2005, 19:88-96.
  30. Houtveen JH, Molenaar PC: Comparison between the Fourier and Wavelet methods of spectral analysis applied to station- ary and nonstationary heart period data. Psychophysiol 2001, 38:729-735.
  31. Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tan- nock R: Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J Abnorm Child Psychol 2003, 31:315-327.
  32. Purvis KL, Tannock R: Phonological processing, not inhibitory control, differentiates ADHD and reading disability. J Am Acad Child Adolesc Psychiatry 2000, 39:485-494.
  33. Kuntsi J, Oosterlaan J, Stevenson J: Psychological mechanisms in hyperactivity: I. Response inhibition deficit, working mem- ory impairment, delay aversion, or something else? J Child Psy- chol Psychiatry 2001, 42:199-210.
  34. Conners CK, Epstein JN, Angold A, Klaric J: Continuous perform- ance test performance in a normative epidemiological sam- ple. J Abnorm Child Psychol 2003, 31:555-562.
  35. Mahone EM, Pillion JP, Hoffman J, Hiemenz JR, Denckla MB: Con- struct validity of the auditory continuous performance test for preschoolers. Dev Neuropsychol 2005, 27:11-33.
  36. Mullins C, Bellgrove MA, Gill M, Robertson IH: Variability in time reproduction: difference in ADHD combined and inattentive subtypes. J Am Acad Child Adolesc Psychiatry 2005, 44:169-176.
  37. Rubia K, Taylor A, Taylor E, Sergeant JA: Synchronization, antici- pation, and consistency in motor timing of children with dimensionally defined attention deficit hyperactivity behav- iour. Percept Mot Skills 1999, 89:1237-1258.
  38. Toplak ME, Rucklidge JJ, Hetherington R, John SC, Tannock R: Time perception deficits in attention-deficit/ hyperactivity disor- der and comorbid reading difficulties in child and adolescent samples. J Child Psychol Psychiatry 2003, 44:888-903.
  39. van Meel CS, Oosterlaan J, Heslenfeld DJ, Sergeant JA: Motivational effects on motor timing in attention-deficit/hyperactivity dis- order. J Am Acad Child Adolesc Psychiatry 2005, 44:451-460.
  40. Hurks PP, Hendriksen JG, Vles JS, Kalff AC, Feron FJ, Kroes M, van Zeben TM, Steyaert J, Jolles J: Verbal fluency over time as a measure of automatic and controlled processing in children with ADHD. Brain Cogn 2004, 55:535-544.
  41. Kuntsi J, Andreou P, Ma J, Borger NA, van der Meere JJ: Testing assumptions for endophenotype studies in ADHD: reliability and validity of tasks in a general population sample. BMC Psy- chiatry 2005, 5:40.
  42. Hervey AS, Epstein JN, Curry JF: Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology 2004, 18:485-503.
  43. Leth-Steensen C, Elbaz ZK, Douglas VI: Mean response times, var- iability, and skew in the responding of ADHD children: a response time distributional approach. Acta Psychol (Amst) 2000, 104:167-190.
  44. Kuntsi J, Stevenson J: Psychological mechanisms in hyperactiv- ity: II. The role of genetic factors. J Child Psychol Psychiatry 2001, 42:211-219.
  45. Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH: Association between dopamine transporter (DAT1) geno- type, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Neuropsychopharmacology 2005, 30:2290-2297.
  46. Loo SK, Specter E, Smolen A, Hopfer C, Teale PD, Reite ML: Func- tional effects of the DAT1 polymorphism on EEG measures in ADHD. J Am Acad Child Adolesc Psychiatry 2003, 42:986-993.
  47. Tannock R, Schachar R, Logan G: Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abnorm Child Psychol 1995, 23:235-266.
  48. AT BR: Elements of the theory of Markov processes and their applications New York: McGraw-Hil; 1960.
  49. Sergeant J, van der Meere JJ: Additive factor method applied to psychopathology with special reference to childhood hyper- activity. Acta Psychol (Amst) 1990, 74:277-295.
  50. Shapiro KL, Raymond JE, Arnell KM: Attention to visual pattern information produces the attentional blink in rapid serial vis- ual presentation. J Exp Psychol Hum Percept Perform 1994, 20:357-371.
  51. Shapiro K, Schmitz F, Martens S, Hommel B, Schnitzler A: Resource sharing in the attentional blink. Neuroreport 2006, 17:163-166.
  52. Armstrong IT, Munoz DP: Attentional blink in adults with atten- tion-deficit hyperactivity disorder. Influence of eye move- ments. Exp Brain Res 2003, 152:243-250.
  53. Li CS, Lin WH, Chang HL, Hung YW: A psychophysical measure of attention deficit in children with attention-deficit/hyper- activity disorder. J Abnorm Psychol 2004, 113:228-236.
  54. Catania AC, Matthews BA, Shimoff E: Instructed versus shaped human verbal behavior: Interactions with nonverbal responding. J Exp Anal Behav 1982, 38:233-248.
  55. Lepine R, Barrouillet P, Camos V: What makes working memory spans so predictive of high-level cognition? Psychon Bull Rev 2005, 12:165-170.
  56. Sergeant J: The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 2000, 24:7-12.
  57. West J, Houghton S, Douglas G, Whiting K: Response inhibition, memory amd attention in boys with attention-deficit/hyper- activity disorder. Educational Psychology 2002, 22:533-551.
  58. Magistretti PJ, Pellerin L: Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 1999, 354:1155-1163.
  59. Ernst M, Zametkin AJ, Matochik J, Schmidt M, Jons PH, Liebenauer LL, Hardy KK, Cohen RM: Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 1997, 17:391-401.
  60. Ronnback L, Hansson E: On the potential role of glutamate transport in mental fatigue. J Neuroinflammation 2004, 1:22.
  61. Dunn SL, Young EA, Hall MD, McNulty S: Activation of astrocyte intracellular signaling pathways by interleukin-1 in rat pri- mary striatal cultures. Glia 2002, 37:31-42.
  62. Ho A, Gore AC, Weickert CS, Blum M: Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. Neuroreport 1995, 6:1454-1458.
  63. Kinor N, Geffen R, Golomb E, Zinman T, Yadid G: Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 2001, 33:143-150.
  64. Shimizu M, Nishida A, Zensho H, Miyata M, Yamawaki S: Down-reg- ulation of 5-hydroxytryptamine7 receptors by dexametha- sone in rat frontocortical astrocytes. J Neurochem 1997, 68:2604-2609.
  65. Tomozawa Y, Inoue T, Satoh M: Expression of type I interleukin- 1 receptor mRNA and its regulation in cultured astrocytes. Neurosci Lett 1995, 195:57-60.
  66. Ohta K, Kuno S, Mizuta I, Fujinami A, Matsui H, Ohta M: Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cul- tured mouse astrocytes. Life Sci 2003, 73:617-626.
  67. Biber K, Laurie DJ, Berthele A, Sommer B, Tolle TR, Gebicke-Harter PJ, van CD, Boddeke HW: Expression and signaling of group I metabotropic glutamate receptors in astrocytes and micro- glia. J Neurochem 1999, 72:1671-1680.
  68. Cooper MS: Intercellular signaling in neuronal-glial networks. Biosystems 1995, 34:65-85.
  69. Glowinski J, Marin P, Tence M, Stella N, Giaume C, Premont J: Glial receptors and their intervention in astrocyto-astrocytic and astrocyto-neuronal interactions. Glia 1994, 11:201-208.
  70. Hertz L, Schousboe I, Hertz L, Schousboe A: Receptor expression in primary cultures of neurons or astrocytes. Prog Neuropsy- chopharmacol Biol Psychiatry 1984, 8:521-527.
  71. Parpura V, Haydon PG: Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci U S A 2000, 97:8629-8634.
  72. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG: Glutamate-mediated astrocyte-neuron signalling. Nature 1994, 369:744-747.
  73. Pellerin L, Magistretti PJ: Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhanc- ing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxa- zolepropionic acid (AMPA) receptor modulators. J Neurochem 2005, 92:668-677.
  74. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW: Neural activity triggers neuronal oxidative metabolism fol- lowed by astrocytic glycolysis. Science 2004, 305:99-103.
  75. Attwell D, Gibb A: Neuroenergetics and the kinetic design of excitatory synapses. Nat Rev Neurosci 2005, 6:841-849.
  76. Gladden LB: Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004, 558:5-30.
  77. Oades RD, Daniels R, Rascher W: Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity dis- order. Psychiatry Res 1998, 80:177-186.
  78. Adell A, Artigas F: The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 2004, 28:415-431.
  79. Zhen J, Chen N, Reith ME: Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates. Neuropharmacology 2005, 49:769-779.
  80. Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S, Singer EA, Sitte HH: Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphet- amines. Neuropharmacology 2005, 49:811-819.
  81. Pellerin L: How astrocytes feed hungry neurons. Mol Neurobiol 2005, 32:59-72. 100. Hansson E, Ronnback L: Altered neuronal-glial signaling in glutamatergic transmission as a unifying mechanism in chronic pain and mental fatigue. Neurochem Res 2004, 29:989-996. 101. Carmona S, Vilarroya O, Bielsa A, Tremols V, Soliva JC, Rovira M, Tomas J, Raheb C, Gispert JD, Batlle S, Bulbena A: Global and regional gray matter reductions in ADHD: a voxel-based morphometric study. Neurosci Lett 2005, 389:88-93. 102.
  82. Rothermundt M, Peters M, Prehn JH, Arolt V: S100B in brain dam- age and neurodegeneration. Microsc Res Tech 2003, 60:614-632. 123.
  83. Zametkin A, Nordahl T, Gross M, King C, Semple W, Rumsey J, Ham- burger S, Cohen R: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. The New England Journal of Medicine 1990, 323:1361-1366. 124. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley J, Ding YS, Wong C, Pappas N: Differences in regional brain metabolic responses between single and repeated doses of methylphe- nidate. Psychiatry Res 1998, 83:29-36. 125. van Leeuwen TH, Steinhausen HC, Overtoom CCE, Pascual-Marqui RD, van't Klooster B, Rothenberger A, Sergeant JA, Brandeis D: The Continuous Performance Test revisited with neuroelectric mapping: impaired orienting in children with attention defi- cits. Behav Brain Res 1998, 94:97-110. 126. Hennighausen K, Schulte-Korne G, Warnke A, Remschmidt H: [Con- tingent negative variation (CNV) in children with hyperki- netic syndrome--an experimental study using the Continuous Performance Test (CPT)]. Z Kinder Jugendpsychiatr Psychother 2000, 28:239-246. 127. Perchet C, Revol O, Fourneret P, Mauguiere F, Garcia-Larrea L: Attention shifts and anticipatory mechanisms in hyperactive children: an ERP study using the Posner paradigm. Biol Psychi- atry 2001, 50:44-57. 128. Strandburg RJ, Marsh JT, Brown WS, Asarnow RF, Higa J, Harper R, Guthrie D: Continuous-processing--related event-related potentials in children with attention deficit hyperactivity dis- order. Biol Psychiatry 1996, 40:964-980. 129.
  84. Yordanova J, Dumais-Huber C, Rothenberger A: Coexistence of tics and hyperactivity in children: no additive at the psycho- physiological level. Int J Psychophysiol 1996, 21:121-133. 130. Kok A: On the utility of P3 amplitude as a measure of processing capacity. Psychophysiol 2001, 38:557-577. 131. Polich J, Kok A: Cognitive and biological determinants of P300: an integrative review. Biol Psychol 1995, 41:103-146. 132. Potgieter S, Vervisch J, Lagae L: Event related potentials during attention tasks in VLBW children with and without attention deficit disorder. Clin Neurophysiol 2003, 114:1841-1849. 133. Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD: Methyl- phenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test. J Abnorm Child Psychol 1991, 19:263-283. 134. Lazzaro I, Anderson J, Gordon E, Clarke S, Leong J, Meares R: Single trial variability within the P300 (250-500 ms) processing win- dow in adolescents with attention deficit hyperactivity disor- der. Psychiatry Res 1997, 73:91-101. 135. Smithee JA, Klorman R, Brumaghim JT, Borgstedt AD: Methylphe- nidate does not modify the impact of response frequency or stimulus sequence on performance and event-related poten- tials of children with attention deficit hyperactivity disorder. J Abnorm Child Psychol 1998, 26:233-245. 136. Sunohara GA, Malone MA, Rovet J, Humphries T, Roberts W, Taylor MJ: Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evi- dence. Neuropsychopharmacology 1999, 21:218-228. 137.
  85. Vermeiren C, Najimi M, Vanhoutte N, Tilleux S, de HI, Maloteaux JM, Hermans E: Acute up-regulation of glutamate uptake medi- ated by mGluR5a in reactive astrocytes. J Neurochem 2005, 94:405-416. 245. Fonseca LL, Monteiro MA, Alves PM, Carrondo MJ, Santos H: Cul- tures of rat astrocytes challenged with a steady supply of glutamate: new model to study flux distribution in the gluta- mate-glutamine cycle. Glia 2005, 51:286-296. 246.
  86. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Per- rin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB: LINGO- 1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004, 7:221-228. 260. Trifunovski A, Josephson A, Ringman A, Brene S, Spenger C, Olson L: Neuronal activity-induced regulation of Lingo-1. Neuroreport 2004, 15:2397-2400. 261. Katsel P, Davis KL, Haroutunian V: Variations in myelin and oli- godendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 2005, 79:157-173. 262. Tsujimoto S, Yamamoto T, Kawaguchi H, Koizumi H, Sawaguchi T: Prefrontal cortical activation associated with working mem- ory in adults and preschool children: an event-related optical topography study. Cereb Cortex 2004, 14:703-712. 263. Ehlis AC, Herrmann MJ, Wagener A, Fallgatter AJ: Multi-channel near-infrared spectroscopy detects specific inferior-frontal activation during incongruent Stroop trials. Biol Psychol 2005, 69:315-331. 264. Barry RJ, Clarke AR, Johnstone SJ: A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin Neurophysiol 2003, 114:171-183. 265. Barry RJ, Clarke AR, Johnstone SJ, Oades RD: Electrophysiology in attention-deficit/hyperactivity disorder. Int J Psychophysiol 2005, 58:1-3. 266. Sakurai T, Yang B, Takata T, Yokono K: [Exogenous lactate sus- tains synaptic activity and neuronal viability, but fails to induce long-term potentiation (LTP)]. Nippon Ronen Igakkai Zasshi 2000, 37:962-965. 267. Saulle E, Centonze D, Martin AB, Moratalla R, Bernardi G, Calabresi P: Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. Stroke 2002, 33:2978-2984. 268. Fairclough SH, Houston K: A metabolic measure of mental effort. Biol Psychol 2004, 66:177-190. 269.

Cited by

Sorted by citations

Authors
Russell, V. A., Oades, R. D., Tannock, R., Killeen, P. R., Auerbach, J. G., Johansen, E. B., & Sagvolden, T.
Affiliations
  • University of Cape Town (ZA)
  • University of Toronto (CA)
  • Arizona State University (US)
  • Ben-Gurion University of the Negev (IL)
  • University of Oslo (NO)
Corresponding author
Vivienne Ann Russell
Venue
Behavioral and Brain Functions
Published
2006
Volume
2
Issue
1
Pages
30
ISSN
1744-9081 (ISSN-L)
OpenAlex
W2130195204
Cited by
241
References
25
Citations by year
2026: 3 · 2025: 12 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 15 · 2020: 2 · 2019: 12 · 2018: 8 · 2017: 11 · 2016: 12 · 2015: 18 · 2014: 16 · 2013: 17 · 2012: 12
FWCI
9.58
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Behavioral and Brain Functions (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion, cc-by)
  • TSpace (University of Toronto) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DuEPublico (University of Duisburg-Essen) (submittedVersion, cc-by)
  • Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
  • University of Cape Town
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
attention deficit hyperactivity disorder, response variability, astrocyte function, oligodendrocytes, myelination, axon development, ATP production, neuronal energy metabolism, energy metabolism genes, glutamate release, glucose transporters, glycolytic enzymes, brain development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review